A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Optimize Rx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 21,800 shares of OPRX stock, worth $113,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,800
Previous 2,800 678.57%
Holding current value
$113,578
Previous $34,000 541.18%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.8 - $13.17 $442,217 - $661,818
50,252 Added 96.27%
102,453 $1.02 Million
Q1 2024

May 15, 2024

SELL
$11.47 - $16.17 $688,704 - $970,911
-60,044 Reduced 53.49%
52,201 $634,000
Q4 2023

Feb 14, 2024

BUY
$7.06 - $14.49 $417,994 - $857,894
59,206 Added 111.63%
112,245 $1.61 Million
Q3 2023

Nov 14, 2023

SELL
$7.43 - $14.96 $278,194 - $560,132
-37,442 Reduced 41.38%
53,039 $412,000
Q2 2023

Aug 14, 2023

SELL
$11.63 - $15.63 $1.14 Million - $1.53 Million
-98,104 Reduced 52.02%
90,481 $1.29 Million
Q1 2023

May 15, 2023

BUY
$12.54 - $19.38 $393,868 - $608,706
31,409 Added 19.98%
188,585 $2.76 Million
Q4 2022

Feb 14, 2023

BUY
$13.77 - $22.04 $805,517 - $1.29 Million
58,498 Added 59.28%
157,176 $2.64 Million
Q3 2022

Nov 14, 2022

BUY
$13.74 - $30.13 $1.36 Million - $2.97 Million
98,678 New
98,678 $1.46 Million
Q1 2022

May 16, 2022

BUY
$35.27 - $62.91 $1.42 Million - $2.54 Million
40,296 Added 330.51%
52,488 $1.98 Million
Q3 2021

Nov 15, 2021

SELL
$50.93 - $85.55 $302,269 - $507,739
-5,935 Reduced 32.74%
12,192 $1.04 Million
Q2 2021

Aug 16, 2021

BUY
$42.76 - $63.33 $474,764 - $703,152
11,103 Added 158.07%
18,127 $1.12 Million
Q1 2021

May 17, 2021

SELL
$33.36 - $62.2 $692,019 - $1.29 Million
-20,744 Reduced 74.7%
7,024 $342,000
Q4 2020

Feb 16, 2021

BUY
$19.04 - $33.1 $528,702 - $919,120
27,768 New
27,768 $865,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $93.9M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.